Blood Reviews
Volume 24, Supplement 1 , Pages S13-S19, November 2010

Lenalidomide mode of action: linking bench and clinical findings

  • Faith Davies

      Affiliations

    • The Institute of Cancer Research and Royal Marsden Hospital, United Kingdom
    • Corresponding Author InformationCorresponding author. The Institute of Cancer Research and Royal Marsden Hospital, 15 Cotswold Road, Sutton, Surrey SM2 5NG, United Kingdom. Tel.: +44 207 352 8133 (ext 4743); fax: +44 0208 642 9634
    • ,
  • Rachid Baz

      Affiliations

    • Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, University of South Florida, United States

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0268-960X(10)70004-7

doi:10.1016/S0268-960X(10)70004-7

Blood Reviews
Volume 24, Supplement 1 , Pages S13-S19, November 2010

Article Tools